(RITM) Rithm Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US64828T2015
Stock: Real Estate, Loans, Investments, Servicing
Total Rating 30
Risk 58
Buy Signal -0.48
| Risk 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Relative Tail Risk | -0.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.67 |
| Alpha | -31.99 |
| Character TTM | |
|---|---|
| Beta | 0.861 |
| Beta Downside | 1.184 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.31% |
| CAGR/Max DD | 0.57 |
EPS (Earnings per Share)
Revenue
Description: RITM Rithm Capital March 05, 2026
Rithm Capital Corp. (RITM) is an asset manager specializing in real estate, credit, and financial services within the United States. The company operates through segments including Origination and Servicing, Residential Transitional Lending, and Asset Management and Investment Portfolio.
Its investment portfolio includes diverse real estate-related assets such as single-family rental properties, real estate securities, and residential mortgage loans. RITM also holds excess mortgage servicing rights, an asset class that typically benefits from rising interest rates.
As a real estate investment trust (REIT), RITM is generally exempt from federal corporate income tax if it distributes at least 90% of its taxable income to shareholders. This structure is common for companies holding income-generating real estate assets.
To further explore Rithm Capital Corp.s financial performance and valuation, consider reviewing its detailed reports on ValueRay.
Headlines to watch out for
- Mortgage interest rate fluctuations impact loan origination volume
- Residential housing market health affects asset valuations
- Regulatory changes in mortgage servicing increase compliance costs
- Investment portfolio performance drives net interest income
- Single-family rental market trends influence property revenues
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 681.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 3.59 > 1.0 |
| NWC/Revenue: -38.72% < 20% (prev -59.35%; Δ 20.63% < -1%) |
| CFO/TA -0.02 > 3% & CFO -1.29b > Net Income 681.4m |
| Net Debt (37.78b) to EBITDA (2.19b): 17.26 < 3 |
| Current Ratio: 0.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (564.7m) vs 12m ago 7.30% < -2% |
| Gross Margin: 92.15% > 18% (prev 0.94%; Δ 9.12k% > 0.5%) |
| Asset Turnover: 11.20% > 50% (prev 10.57%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 1.22 > 6 (EBITDA TTM 2.19b / Interest Expense TTM 1.73b) |
Altman Z'' 0.02
| A: -0.04 (Total Current Assets 1.85b - Total Current Liabilities 4.00b) / Total Assets 53.07b |
| B: -0.00 (Retained Earnings -19.9m / Total Assets 53.07b) |
| C: 0.04 (EBIT TTM 2.12b / Avg Total Assets 49.56b) |
| D: 0.00 (Book Value of Equity 56.7m / Total Liabilities 43.81b) |
| Altman-Z'' Score: 0.02 = B |
Beneish M -3.11
| DSRI: 0.71 (Receivables 3.81b/4.72b, Revenue 5.55b/4.87b) |
| GMI: 1.02 (GM 92.15% / 93.99%) |
| AQI: 1.00 (AQ_t 0.96 / AQ_t-1 0.96) |
| SGI: 1.14 (Revenue 5.55b / 4.87b) |
| TATA: 0.04 (NI 681.4m - CFO -1.29b) / TA 53.07b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of RITM shares?
As of March 24, 2026, the stock is trading at USD 9.06 with a total of 19,969,065 shares traded.
Over the past week, the price has changed by -3.51%, over one month by -9.49%, over three months by -16.11% and over the past year by -15.97%.
Over the past week, the price has changed by -3.51%, over one month by -9.49%, over three months by -16.11% and over the past year by -15.97%.
Is RITM a buy, sell or hold?
Rithm Capital has received a consensus analysts rating of 4.64.
Therefore, it is recommended to buy RITM.
- StrongBuy: 7
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RITM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.5 | 60% |
| Analysts Target Price | 14.5 | 60% |
RITM Fundamental Data Overview March 21, 2026
P/E Trailing = 8.6827
P/E Forward = 3.9262
P/S = 1.3278
P/B = 0.7131
Revenue TTM = 5.55b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 35.45b USD (from longTermDebt, last quarter)
Short Term Debt = 4.00b USD (from shortTermDebt, last quarter)
Debt = 39.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 37.78b USD (from netDebt column, last quarter)
Enterprise Value = 42.79b USD (5.02b + Debt 39.62b - CCE 1.85b)
Interest Coverage Ratio = 1.22 (Ebit TTM 2.12b / Interest Expense TTM 1.73b)
EV/FCF = -56.12x (Enterprise Value 42.79b / FCF TTM -762.6m)
FCF Yield = -1.78% (FCF TTM -762.6m / Enterprise Value 42.79b)
FCF Margin = -13.73% (FCF TTM -762.6m / Revenue TTM 5.55b)
Net Margin = 12.27% (Net Income TTM 681.4m / Revenue TTM 5.55b)
Gross Margin = 92.15% ((Revenue TTM 5.55b - Cost of Revenue TTM 435.9m) / Revenue TTM)
Gross Margin QoQ = 90.95% (prev 92.28%)
Tobins Q-Ratio = 0.81 (Enterprise Value 42.79b / Total Assets 53.07b)
Interest Expense / Debt = 1.11% (Interest Expense 440.0m / Debt 39.62b)
Taxrate = 10.95% (88.3m / 806.4m)
NOPAT = 1.88b (EBIT 2.12b * (1 - 10.95%))
Current Ratio = 0.46 (Total Current Assets 1.85b / Total Current Liabilities 4.00b)
Debt / Equity = 4.70 (Debt 39.62b / totalStockholderEquity, last quarter 8.43b)
Debt / EBITDA = 17.26 (Net Debt 37.78b / EBITDA 2.19b)
Debt / FCF = -49.53 (negative FCF - burning cash) (Net Debt 37.78b / FCF TTM -762.6m)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.37% (Net Income 681.4m / Total Assets 53.07b)
RoE = 8.35% (Net Income TTM 681.4m / Total Stockholder Equity 8.16b)
RoCE = 4.85% (EBIT 2.12b / Capital Employed (Equity 8.16b + L.T.Debt 35.45b))
RoIC = 4.75% (NOPAT 1.88b / Invested Capital 39.68b)
WACC = 1.89% (E(5.02b)/V(44.64b) * Re(9.01%) + D(39.62b)/V(44.64b) * Rd(1.11%) * (1-Tc(0.11)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.10%
[DCF] Fair Price = unknown (Cash Flow -762.6m)
EPS Correlation: 78.58 | EPS CAGR: 20.30% | SUE: 3.47 | # QB: 1
Revenue Correlation: 70.83 | Revenue CAGR: 14.93% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.54 | Chg7d=+0.000 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.006 | Chg30d=+0.011 | Revisions Net=-1 | Growth EPS=-3.6% | Growth Revenue=+14.7%
EPS next Year (2027-12-31): EPS=2.31 | Chg7d=+0.007 | Chg30d=-0.045 | Revisions Net=+0 | Growth EPS=+2.1% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 9.0% - Earnings Yield 11.5%)
[Growth] Growth Spread = +6.5% (Analyst 4.0% - Implied -2.5%)
P/E Forward = 3.9262
P/S = 1.3278
P/B = 0.7131
Revenue TTM = 5.55b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 35.45b USD (from longTermDebt, last quarter)
Short Term Debt = 4.00b USD (from shortTermDebt, last quarter)
Debt = 39.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 37.78b USD (from netDebt column, last quarter)
Enterprise Value = 42.79b USD (5.02b + Debt 39.62b - CCE 1.85b)
Interest Coverage Ratio = 1.22 (Ebit TTM 2.12b / Interest Expense TTM 1.73b)
EV/FCF = -56.12x (Enterprise Value 42.79b / FCF TTM -762.6m)
FCF Yield = -1.78% (FCF TTM -762.6m / Enterprise Value 42.79b)
FCF Margin = -13.73% (FCF TTM -762.6m / Revenue TTM 5.55b)
Net Margin = 12.27% (Net Income TTM 681.4m / Revenue TTM 5.55b)
Gross Margin = 92.15% ((Revenue TTM 5.55b - Cost of Revenue TTM 435.9m) / Revenue TTM)
Gross Margin QoQ = 90.95% (prev 92.28%)
Tobins Q-Ratio = 0.81 (Enterprise Value 42.79b / Total Assets 53.07b)
Interest Expense / Debt = 1.11% (Interest Expense 440.0m / Debt 39.62b)
Taxrate = 10.95% (88.3m / 806.4m)
NOPAT = 1.88b (EBIT 2.12b * (1 - 10.95%))
Current Ratio = 0.46 (Total Current Assets 1.85b / Total Current Liabilities 4.00b)
Debt / Equity = 4.70 (Debt 39.62b / totalStockholderEquity, last quarter 8.43b)
Debt / EBITDA = 17.26 (Net Debt 37.78b / EBITDA 2.19b)
Debt / FCF = -49.53 (negative FCF - burning cash) (Net Debt 37.78b / FCF TTM -762.6m)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.37% (Net Income 681.4m / Total Assets 53.07b)
RoE = 8.35% (Net Income TTM 681.4m / Total Stockholder Equity 8.16b)
RoCE = 4.85% (EBIT 2.12b / Capital Employed (Equity 8.16b + L.T.Debt 35.45b))
RoIC = 4.75% (NOPAT 1.88b / Invested Capital 39.68b)
WACC = 1.89% (E(5.02b)/V(44.64b) * Re(9.01%) + D(39.62b)/V(44.64b) * Rd(1.11%) * (1-Tc(0.11)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.10%
[DCF] Fair Price = unknown (Cash Flow -762.6m)
EPS Correlation: 78.58 | EPS CAGR: 20.30% | SUE: 3.47 | # QB: 1
Revenue Correlation: 70.83 | Revenue CAGR: 14.93% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.54 | Chg7d=+0.000 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.006 | Chg30d=+0.011 | Revisions Net=-1 | Growth EPS=-3.6% | Growth Revenue=+14.7%
EPS next Year (2027-12-31): EPS=2.31 | Chg7d=+0.007 | Chg30d=-0.045 | Revisions Net=+0 | Growth EPS=+2.1% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 9.0% - Earnings Yield 11.5%)
[Growth] Growth Spread = +6.5% (Analyst 4.0% - Implied -2.5%)